Internalization of anti-nucleolin antibody into viable HEp-2 cells

Abstract

Anti-nucleolin antibodies have been detected in patients with systemic connective tissue diseases (SCTD) including systemic sclerosis (SSc) and systemic lupus erythematosus (SLE). In vivo bound autoantibodies to nucleoli of epidermal keratinocytes have been demonstrated in skin from patients with SCTD. In this study, monoclonal antibody to nucleolin (D-3) was used to determine the distribution of nucleolin in different culture cells including HEp-2, HepG2, HRCC, Molt-4 and Wil2 cells. Nucleolin was found to be present on the surface of HEp-2 and HepG2 cells, but not on the surface of HRCC and lymphoblastoid (Molt-4 and Wil2) cells; in contrast, nucleolin was detected in the nucleoli of all permeabilized cells examined. In immunoprecipitation, using extracts from 32P-labeled HEp-2 cells as antigenic source, cell membrane as well as nuclear nucleolins were found to be phosphorylated with a molecular weight of 105 kDa. Viable HEp-2 and HepG2 cells were cocultured with IgG fraction of D-3 in a CO2 incubator for 1 to 24 h, and then permeabilized with acetone followed by immunofluorescence staining with FITC-labeled goat anti-mouse IgG antibodies. Nucleolar staining was observed in cells after 10 h or longer of coculture. These data indicated that D-3 antibody reacted with cell membrane nucleolin and subsequently gain access into cells in a process related to pinocytosis.

This is a preview of subscription content, access via your institution.

References

  1. 1.

    Olson MOJ & Busch H (1978) In: Skin GI and Kleinsmith L (eds) Methods in Chromosomal Protein Research (pp 163–210) Academic Press, Inc, New York

    Google Scholar 

  2. 2.

    Olson MOJ, Guetzow K & Busch H (1981) Exp. Cell. Res. 135: 259–265

    Google Scholar 

  3. 3.

    Bugler B, Caizergues-Ferrer M, Bouche G, Bourbon H & Amalric F (1982) Eur. J. Biochem. 128: 475–480

    Google Scholar 

  4. 4.

    Bouche G, Caizergues-Ferrer M, Bugler B & Amalric F (1984) Nucleic. Acid. Res. 12:3025–3035

    Google Scholar 

  5. 5.

    Semenkovich CF, Ostlund RE, Olson MOJ & Yang JW (1990) Biochemistry 29: 708–713

    Google Scholar 

  6. 6.

    Tan EM: Antinuclear antibodies (1989) Adv. Immunol. 44: 93–151

    Google Scholar 

  7. 7.

    Prystowsky DS, Gilliam JN & Tuffanelli DL (1978) Arch. Dermatol. 114: 536–538

    Google Scholar 

  8. 8.

    Deng JS & Ballou BR (1993) J. Invest. Derm. 100: 527

    Google Scholar 

  9. 9.

    Ballou BT, Fisher G, Deng JS, Reiland JM, Waggoner AS & Hakala TR (1993) FASEB J. 7: 1308

    Google Scholar 

  10. 10.

    Deng JS & Kumar V (1987) In: Beutner EH, Chorzelski TP & Kumar V (eds) Immunopathology of the skin, 3rd edition (pp 533–553) John Wiley & Sons, New York

    Google Scholar 

  11. 11.

    Liebert M, Ballou BT, Taylor RJ, Reiland JM & Hakala TR (1985) J. Immunol. Methods 85: 97–104

    Google Scholar 

  12. 12.

    West MA, Bretscher MS & Watts C (1989) J. Cell. Biol. 109: 2731–2739

    Google Scholar 

  13. 13.

    Kovacsovics-Bankowski M, Clark K, Benacerraf B & Rock KL (1993) Proc. Natl. Acad. Sci. (USA) 90: 4942–4946

    Google Scholar 

  14. 14.

    Srivastava M, Fleming PJ, Pollard HB & Burns AL (1989) FEBS Lett. 250: 99–105

    Google Scholar 

  15. 15.

    Lischwe MA, Richards RL, Busch RK & Busch M (1981) Exp. Cell. Res. 136: 101–105

    Google Scholar 

  16. 16.

    Chen CM, Chiang SY & Yeh NS (1991) J. Biol. Chem. 266: 7754–7758

    Google Scholar 

  17. 17.

    Sapp M, Richter A, Weisshart K, Caizergues-Ferrer M, Amalric F, Wallace MO, Kirstein MN & Olson MOJ (1989) Eur. J. Biochem. 179: 541–548

    Google Scholar 

  18. 18.

    Ballou B, Fisher GW, Deng JS, Reiland JM, Hakala TR, Srivastava M & Farkas DL (1996) Proc. Soc. Photo-Optical Instrum. Eng. 2680: 123–131

    Google Scholar 

Download references

Author information

Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Deng, JS., Ballou, B. & Hofmeister, J.K. Internalization of anti-nucleolin antibody into viable HEp-2 cells. Molecular Biology Reports 23, 191–195 (1996). https://doi.org/10.1007/BF00351168

Download citation

Key words

  • in vivo antinuclear antibody
  • nucleolin